A stimulation device includes an energy source; an electronics unit; an actuator that is coupled with the electronics unit and/or the energy source. The electronics unit includes a controller. The energy source, the electronics unit and the actuator are arranged in a housing. A fixing unit which is coupled with the housing and affixes the stimulation device on a heart or in a heart. The actuator emits electromagnetic waves for the stimulation of genetically manipulated tissue, and the controller controls the stimulation of the tissue by way of the electromagnetic waves of the actuator.

Embodiments of the present disclosure provide systems, apparatuses and methods for regulation hormone production in mammals. Examples include but are not limited to by creating electro-magnetic wave emission pulse trains (photons) of individual color spectrums in sufficient intensity to drive hormone production in a mammal, using a characteristic frequency or pattern to minimize the required input power necessary to regulate hormone production, while also allowing for the monitoring of the power consumption and other variables of the system. By controlling the duty cycle, intensity, wavelength band and frequency of photon signals to a mammal, production of specific hormones can be regulated through the cycling between blue, green, yellow, near-red, far-red, infrared and ultra violet photon modulation.

A method of administering light treatment to a biological surface comprising administering light therapy from one or more light sources and administering distraction stimulus from one or more distraction mechanisms. The distraction stimulus is configured to distract a user from a discomfort caused by the light therapy.

An applicator comprising a reservoir configured to hold a formula, a roller ball configured to apply the formula, a contact-less piston, configured to dispense the formula, and a piston magnet disposed underneath the contact-less piston, wherein the piston magnet is configured to move the piston in response to a magnetic field.

A skin care system including a dispensing device configured to administer a light therapy and a plasma treatment, and an applicator configured to apply a formula, comprising a reservoir configured to hold the formula, a roller ball configured to apply the formula, an attachment configured to attach the cartridge to the dispensing device, and a microcontroller configured to direct the dispensing devices to apply the plasma treatment.

A system for performing a treatment procedure, comprising a robotic movement controller coupled to a treatment device, the robotic movement controller configured to control movement of the treatment device in three dimensions. A manual override system configured to interrupt the robotic movement controller to allow a user to manually control movement of the treatment device. The robotic movement controller is configured to resume operations when the user has completed manual movement of the treatment device.

A system for controlling a laser treatment, comprising a three dimensional image generator configured to receive three dimensional surface data and to generate a user display of the three dimensional surface data, a user control configured to allow a user to select one or more sections from the user display of the three dimensional surface data and to assign a laser wavelength to the selected section and a robotic treatment device configured to receive the assigned laser wavelength and the selected section and to control a laser device to deliver a laser treatment to the selected section at the assigned laser wavelength.

A garment includes a fabric base layer and at least one side-emitting optical fiber retained to or integrated with the fabric base layer. The fabric base layer can stretch in the grain and cross grain direction of the fabric base layer. The at least one side-emitting optical fiber is located in at least one light-emitting zone to be located over a targeted body area of the person wearing the garment, and is configured to receive light from a light source and in the at least one light-emitting zone is configured to project light having a therapeutic wavelength toward the targeted body area.

A method of mitigating the development of myopia, includes measuring elasticity of collagen of an eye; identifying an eye for which the elasticity measured is above a preselected threshold; selectively applying a collagen cross-linking reagent proximate collagen of a sclera of a posterior pole portion of the eye for which the elasticity measured is above the preselected threshold; and irradiating at least the posterior pole portion of the eye with radiation of an appropriate wavelength to initiate covalent bonding and cross-linking of the collagen for which the elasticity measured is above the preselected threshold.

Embodiments of the present disclosure provide systems, apparatuses and methods for regulation hormone production in mammals. Examples include but are not limited to by creating electro-magnetic wave emission pulse trains (photons) of individual color spectrums in sufficient intensity to drive hormone production in a mammal, using a characteristic frequency or pattern to minimize the required input power necessary to regulate hormone production, while also allowing for the monitoring of the power consumption and other variables of the system. By controlling the duty cycle, intensity, wavelength band and frequency of photon signals to a mammal, production of specific hormones can be regulated through the cycling between blue, green, yellow, near-red, far-red, infrared and ultra violet photon modulation.